Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

Overdiagnosis in Lung Cancer Screening: Still the Unavoidable Cost of Doing Business? — SciRadar

Back to results

Annals of thoracic surgery short reports

Overdiagnosis in Lung Cancer Screening: Still the Unavoidable Cost of Doing Business?

Riccardo Orlandi, Luigi Rolli, Ugo Pastorino

Published: 202510.1016/j.atssr.2025.01.002

No abstract available for this study.